Manchester University NHS Foundation Trust (MFT)

Manchester MI39WL

0 studies enrolling now · 3 studies all time

What they study most

Familial Chylomicronemia Syndrome, Moderate Hemophilia A, Severe Hemophilia A, Severe Hypertriglyceridemia

Studies at this site

• A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) — Completed